Improving alloimmunized pregnancy outcomes: New QuidelOrtho and Allo Hope Foundation partnership

QuidelOrtho and the Allo Hope Foundation have teamed up to achieve their shared goal of advancing prenatal care. This new partnership will center on the education and early diagnosis of maternal red blood cell alloimmunization, according to an announcement.

The companies will work together to close care gaps by developing patient empowering resources. They aim to “increase awareness among healthcare providers and help ensure women receive informed, equitable prenatal testing and care from the very beginning.” These educational resources will start becoming accessible through QuidelOrtho’s and Allo Hope Foundation’s digital channels this summer.